STOCK TITAN
  1. Home
  2. Sec-filings
  3. TARS
  4. [Form 4] Tarsus Pharmaceuticals, Inc. Insider Trading Activity

Tarsus (TARS) director Scott Morrison settles 2,954 RSUs into stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tarsus Pharmaceuticals director Scott W. Morrison reported a routine equity compensation event. On June 12, 2026, 2,954 Restricted Stock Units (RSUs) vested and were settled into 2,954 shares of common stock at a per-share price of $0.00, reflecting a derivative exercise.

Following this settlement, Morrison directly held 7,638 shares of Tarsus common stock. He also indirectly held 6,016 shares through the Morrison-Minton Family 2004 Trust, where he serves as trustee and he and his spouse are the sole beneficiaries. No open-market purchases or sales were reported in this filing.

Positive

  • None.

Negative

  • None.
Insider Morrison Scott W
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 2,954 $0.00 $0.00
Exercise Common Stock 2,954 $0.00 $0.00
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 7,638 shares (Direct); Common Stock — 6,016 shares (Indirect, By Morrison-Minton Family 2004 Trust)
Footnotes (4)
  1. F1. The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
  2. F2. The Reporting Person is trustee of the Morrison-Minton Family 2004 Trust, and the Reporting Person and his spouse are the sole beneficiaries of the trust.
  3. F3. Each RSU represents a contingent right to receive one share of the Company's common stock.
  4. F4. RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
RSUs settled 2,954 shares RSUs converted to common stock on June 12, 2026
Settlement price $0.00 per share RSU-to-common stock conversion price
Direct holdings after transaction 7,638 shares Common stock directly owned after RSU settlement
Indirect trust holdings 6,016 shares Common stock held via Morrison-Minton Family 2004 Trust
Derivative exercises 1 transaction, 2,954 shares Exercise/conversion events in this Form 4
Restricted Stock Units financial
"The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for the RSU settlement."
Morrison-Minton Family 2004 Trust financial
"By Morrison-Minton Family 2004 Trust, and the Reporting Person and his spouse are the sole beneficiaries."
non-employee director financial
"RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Tarsus (TARS) director Scott W. Morrison report?
Scott W. Morrison reported the vesting and settlement of 2,954 RSUs into common stock. This was a compensation-related derivative exercise, not an open-market trade, and reflects stock-based pay tied to his role as a non-employee director.

How many Tarsus (TARS) shares does Scott W. Morrison hold after this Form 4?
After the RSU settlement, Scott W. Morrison directly held 7,638 shares of Tarsus common stock. He also indirectly held 6,016 shares through the Morrison-Minton Family 2004 Trust, where he is trustee and a beneficiary.

Were there any open-market buys or sells by Scott W. Morrison in this TARS Form 4?
No open-market buys or sells were reported. The filing only shows a derivative exercise where 2,954 RSUs converted into an equal number of common shares at $0.00 per share, consistent with stock-based compensation vesting.

What are the Restricted Stock Units mentioned in the Tarsus (TARS) Form 4?
The Restricted Stock Units, or RSUs, each represent a right to receive one Tarsus common share. These RSUs vested and were settled into 2,954 common shares, reflecting equity compensation for Morrison’s service as a non-employee director.

How are the Morrison-Minton Family 2004 Trust holdings in Tarsus (TARS) described?
The filing shows 6,016 shares of Tarsus common stock held indirectly via the Morrison-Minton Family 2004 Trust. Morrison is the trustee, and he and his spouse are the sole beneficiaries of this trust.

Were the RSUs in the Tarsus (TARS) Form 4 tied to Morrison’s board service?
Yes. Footnotes state the RSUs were granted on June 12, 2025 in connection with Morrison’s role as a non-employee director, vesting in full on the one-year anniversary of the grant date, subject to continuous service.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Morrison Scott W
(Last)(First)(Middle)
15440 LAGUNA CANYON ROAD, SUITE 160
(Street)
IRVINE CALIFORNIA 92673
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Tarsus Pharmaceuticals, Inc. [ TARS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/12/2026M(1)2,954A(1)7,638D
Common Stock6,016IBy Morrison-Minton Family 2004 Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(3)06/12/2026M2,954 (4) (4)Common Stock2,954$00D
Explanation of Responses:
1. The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
2. The Reporting Person is trustee of the Morrison-Minton Family 2004 Trust, and the Reporting Person and his spouse are the sole beneficiaries of the trust.
3. Each RSU represents a contingent right to receive one share of the Company's common stock.
4. RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Remarks:
/s/ Jeffrey Farrow, Attorney-in-Fact06/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR